Correlation of Breast Imaging Reporting and Data System (BI-RADS) Classification with Histopathological Findings in Patients with Breast Lesions
Keywords:
Bi-Rads, Breast Lesions, Histopathology, Breast Cancer, Diagnostic Accuracy, Radiological–Histopathological Correlation.Abstract
Background: Breast lesions encompass a wide spectrum of benign and malignant conditions requiring accurate diagnosis for appropriate clinical management. The Breast Imaging Reporting and Data System (BI-RADS) provides standardized radiological classification and malignancy risk assessment. This study aimed to correlate BI-RADS classification with histopathological findings and evaluate its diagnostic performance in patients with breast lesions.
Materials and Methods: This hospital-based, observational, cross-sectional study included 90 patients with breast lesions who underwent mammography, ultrasonography, or both, followed by histopathological examination. Lesions were categorized according to BI-RADS classification and correlated with histopathological diagnoses. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were evaluated.
Results: Among 90 patients, 96.67% were females, and breast lump was the predominant presenting complaint (72.22%). Histopathological examination revealed 58 benign (64.44%) and 32 malignant (35.56%) lesions. Fibroadenoma (31.11%) was the most common benign lesion, while invasive breast carcinoma of no special type (25.56%) was the predominant malignancy. Malignancy rates increased progressively from 4.17% in BI-RADS 3 to 11.11%, 50.00%, 90.00%, and 100% in BI-RADS 4A, 4B, 4C, and 5, respectively. BI-RADS demonstrated sensitivity of 96.88%, specificity of 60.34%, PPV of 57.41%, NPV of 97.22%, and overall diagnostic accuracy of 73.33%.
Conclusion: BI-RADS classification demonstrated high sensitivity and negative predictive value in identifying malignant breast lesions. Radiological–histopathological correlation remains essential for accurate diagnosis, appropriate biopsy selection, and effective clinical management.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.



